Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart procedure aims to free patients from Long-Term medication
Disease control CompletedThis study tested a new device that uses electrical pulses to treat a type of irregular heartbeat called paroxysmal atrial fibrillation. The goal was to see if the procedure could keep the heart in normal rhythm for a year without needing anti-arrhythmic drugs. A total of 142 peo…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 05:27 UTC
-
New heart tool aims to stop AFib episodes without lifelong drugs
Disease control CompletedThis study tested a special catheter and generator system to treat paroxysmal atrial fibrillation (PAF), a condition where the heart beats irregularly. 135 adults with PAF that didn't improve with medication took part. The procedure uses heat energy to isolate the pulmonary veins…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
New heart catheter shows promise for stubborn irregular heartbeat
Disease control CompletedThis study tested a special catheter system to treat people with paroxysmal atrial fibrillation (a type of irregular heartbeat) that didn't get better with medication. 237 participants underwent a procedure to isolate the heart's pulmonary veins using the THERMOCOOL SMARTTOUCH SF…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThis study tested the safety and effectiveness of a new catheter system (OMNYPULSE with TRUPULSE generator) for treating paroxysmal atrial fibrillation, a type of irregular heartbeat. 188 participants underwent a procedure to isolate the pulmonary veins using this system. The mai…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Balloon zaps heart rhythm problem in landmark trial
Disease control CompletedThis study tested a special balloon catheter that uses radiofrequency energy to treat people with a heart condition called paroxysmal atrial fibrillation (irregular heartbeat). The trial included 397 adults aged 18-75 who had not responded to medication. The goal was to see if th…
Phase: PHASE3 • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC